Open access
Sep 2026
Mechanisms of acquired resistance to osimertinib in EGFR T790M-Positive lung adenocarcinoma
Remarkable heterogeneity characterizes the resistance mechanisms emerging against osimertinib in EGFR T790M-positive lung adenocarcinoma, with EGFR secondary mutations, bypass signaling pathway activation, and histological transformation representing the primary categories.
Ke-Fan Cui, Ren-Jie Zhu, Jing-Meng Li
· Frontiers in Genetics · 0 citations